University Hospital Würzburg at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University Hospital Würzburg brings 6 presentations to ESGCT 2026 in Hamburg. Its work centres on new targets and technologies for CAR T cells, including combinations aimed at resistant solid tumours and gene-modified NK cells for lymphoma. Other strands cover transposon-based production and moving manufacturing closer to the patient.
| Organization | ESGCT 2026 Attendance |
|---|---|
University Hospital Würzburg Würzburg, Germany | |
German university hospital with research on new CAR-T cell targets, technologies and manufacturing. | Workshop Tue Oct 27 9:40am–11:00am From Vein-to-Vein to On-Demand: Rethinking Manufacturing Infrastructure for Advanced Therapies Manufacturing, CMC and access Poster Wed Oct 28 1:30pm–3:30pm Development of a New Immunotherapy Treatment Based on Gene-Modified Adaptive NK Cells for the Refractory Lymphomas Poster Wed Oct 28 1:30pm–3:30pm Fadeaway Sleeping Beauty Transposase enhances biosafety in CAR T-cell production Poster Wed Oct 28 1:30pm–3:30pm Gene transfer strategy-dependent spatiotemporal CAR expression patterns determine effector function and antigen-response of CAR-T cells Poster Thu Oct 29 2:00pm–4:00pm Combining CAR-modified immune cells to overcome cancer resistance in solid tumors Talk Thu Oct 29 4:00pm–6:00pm New Targets and Technologies for CAR-T Cells Cell therapies and CAR-TManufacturing, CMC and access |
Instantly find 20 buyers from University Hospital Würzburg
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction